DENTSPLY SIRONA Inc. (XRAY) DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The Connected Technology Solutions segment offers imaging equipment, motorized dental handpieces, treatment centers, and other instruments; and intraoral scanners, 3-D printers, and mills, as well as CEREC, a full-chairside economical restoration of esthetic ceramic dentistry offering. The Essential Dental Solutions segment provides motorized endodontic handpieces, files, sealers, irrigation needles, and other tools for root canal procedures; restorative products; curing light and dental diagnostic systems; ultrasonic scalers and polishers; and dental anesthetics, prophylaxis paste, dental sealants, and impression materials. The Orthodontic and Implant Solutions segment offers SureSmile, a clear aligner solution that includes whitening kits and retainers; VPro, a high frequency vibration technology device; SureSmile Simulator; DS Core platform, which creates 3D visualization of patient outcomes; dental implant products; digital dentures; crown and bridge porcelain products; bone regenerative and restorative solutions; treatment planning software; educational programs; custom abutments; tapered immediate load screws; regenerative bone growth factor; artificial teeth; and precious metal dental alloys. The Wellspect Healthcare segment offers medical devices, including catheters for urinary retention and advanced irrigation systems to help people suffering from chronic or severe constipation. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina.
Sector: Dental Equipment & Supplies
Industry: Medical - Instruments & Supplies
DENTSPLY SIRONA Inc. NASDAQ:XRAY Healthcare · Medical - Instruments & Supplies
Mkt Cap $1.9B
Div Yield 1.68%
Prev close $9.46 Close $9.54 Now $9.53 VOL 5.74M $ Vol $54.59M RVOL 1.16x
Mkt Cap $1.9B
VOL 5.74M sh
$ Vol $54.59M
RVOL 1.16×
Div Yield 1.68%
Press Release ● Major ⚠ 5
Dentsply Sirona Reports Third Quarter 2026 Results
Dentsply Sirona reported Q3 2026 net sales of $836 million, down 7.6% year-over-year, with a GAAP diluted loss per share of $0.01 and adjusted EPS of $0.29, down 29.4% from $0.42.
Positives included record quarterly sales at Wellspect Healthcare (up 10.1%), GAAP gross margin expansion to 52.9% from 48.8%, and completion of the U.S. Surity portfolio launch. However, results included a $39 million one-time inventory-profit-estimate benefit that boosted gross profit and adjusted earnings by roughly $30 million.
Free cash flow was zero versus $40 million a year ago, and operating cash flow fell to $32 million from $79 million on unfavorable working capital.
The company updated its FY2026 outlook to approximately $3.5 billion in net sales and adjusted EPS of $1.20-$1.30, excluding a $0.17 one-time tariff-refund benefit, as management emphasized execution of its Return-to-Growth Action Plan amid challenging industry conditions.
• 4d ago AI analysis › Press Release
Dentsply Sirona to Host Third Quarter 2026 Conference Call on November 5
Dentsply Sirona announced it will host its third quarter 2026 earnings conference call and webcast on Thursday, November 5, 2026, at 4:30 p.m. EST.
The release contains no financial results; earnings materials will be posted on the company's investor relations website prior to the call.
This is a scheduling notice only -- the substantive Q3 results will come with the November 5 release.
• 20d ago AI analysis › Press Release ⚠ 1
Wellspect HealthCare Announces U.S. Medicare Reimbursement Access for Surity™ Urinary Management Portfolio
Wellspect HealthCare, a subsidiary of Dentsply Sirona, announced that its Surity™ urinary management portfolio may be covered by traditional Medicare for eligible beneficiaries when medically necessary.
Reimbursement access is supported by HCPCS coding verification under codes A6590 for the external catheters and E2001 for the Urinary Management System, reducing barriers to at-home care for people with severe urinary incontinence.
The Surity™ Urinary Management System launched in the U.S. on August 18, completing the portfolio; Medicare coverage expands the addressable market among the more than 13 million Americans living with urinary incontinence, though no financial impact was quantified.
• 1mo ago AI analysis › Press Release
Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement
Dentsply Sirona announced an expanded agreement with Midwest Dental Equipment & Supply, effective November 1, 2026, adding its digital dentistry technology portfolio to a relationship previously focused on consumables.
This is the seventh North American dealer partnership enhancement of 2026, following agreements with Benco, Burkhart, Nashville Dental, Atlanta Dental, Medline Sinclair, and a renewed Patterson Dental partnership.
The deals support the company's strategy to widen customer access and accelerate adoption of its connected technology ecosystem, though no financial terms were disclosed.
• 1mo ago AI analysis › Press Release
Dentsply Sirona to Participate in the Baird 2026 Global Healthcare Conference
Dentsply Sirona will participate in the Baird 2026 Global Healthcare Conference, with management scheduled to present on Tuesday, September 15, 2026, at 11:25 a.m. ET.
A live audio webcast and an audio replay will be available through the Investors section of the company's website at investor.dentsplysirona.com.
The release is a routine IR calendar notice and contains no new financial, operational, or strategic disclosures.
• 2mo ago AI analysis › Press Release
New At-Home Surity™ Urinary Management System Designed to Provide Comfort and Reliable Care for People Living with Urinary Incontinence
Wellspect HealthCare, a subsidiary of Dentsply Sirona, announced the U.S. launch of the Surity™ Urinary Management System, an at-home urine collection device designed for people living with urinary incontinence.
The launch completes the full Surity portfolio, which already includes male and female external catheters, and features quiet operation and odor reduction to support daily and overnight routines.
The product addresses a gap in reliable care options for the more than 13 million Americans affected by urinary incontinence and is available immediately for home purchase.
• 2mo ago AI analysis › Press Release ⚠ 3
Dentsply Sirona Reports Second Quarter 2026 Results
Dentsply Sirona reported second quarter 2026 net sales of $898 million, a 4.1% decrease from the prior year, while adjusted EPS remained flat at $0.52.
The company swung to a GAAP profit of $0.18 per share compared to a loss last year, driven by a 260 basis point expansion in GAAP gross margin to 54.9% and a significant increase in free cash flow to $55 million.
Management reaffirmed its full-year 2026 guidance for sales of $3.5 billion to $3.6 billion and adjusted EPS of $1.40 to $1.50, and repurchased 1.3 million shares during the quarter.
• 3mo ago AI analysis › Press Release
Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship
Dentsply Sirona is expanding its relationship with Medline Sinclair to distribute its technology portfolio across Canada starting September 1, 2026.
The deal broadens a previously consumables-focused partnership to include digital dentistry solutions, leveraging Medline Sinclair's nationwide sales network.
This marks the sixth dealer network enhancement announced by the company in 2026 as part of its North America commercial growth strategy.
• 3mo ago AI analysis › Press Release
Dentsply Sirona to Host Second Quarter Conference Call on August 6th
Dentsply Sirona announced it will host an investor conference call on August 6, 2026, at 4:30 p.m. ET to discuss its second quarter 2026 financial results.
Financial earnings materials and the live webcast link will be made available on the Investors section of the company's website prior to the call.
Wade Moody, Senior Manager of Investor Relations, was listed as the contact for investor inquiries regarding the event.
• 3mo ago AI analysis › Press Release
PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry
PDS Health and Dentsply Sirona announced that supported practices have surpassed five million CEREC chairside restorations, a milestone highlighting the scale of digital workflows across the network.
The achievement involves over 1,200 installed CEREC systems and demonstrates sustained clinician adoption, enabling same-day restorative capabilities and improved efficiency.
Executives emphasized that the long-standing collaboration has successfully integrated digital solutions to deliver predictable outcomes and a more convenient patient experience.
• 4mo ago AI analysis › Press Release
Dentsply Sirona Appoints John Fortson as Chief Financial Officer
Dentsply Sirona (XRAY) has appointed John Fortson as its new Chief Financial Officer, effective July 20, 2026.
Fortson joins from Kymera International, where he served as CFO, and previously held CEO and CFO roles at Ingevity Corporation (NGVT).
The appointment is part of Dentsply Sirona's 'Return-to-Growth Action Plan,' with CEO Dan Scavilla citing Fortson's public company experience and operational track record as key factors.
• 4mo ago AI analysis › Press Release
Dentsply Sirona Continues to Expand U.S. Distribution Network to Strengthen Access to its Digital Dentistry Solutions Across Key Regional Markets
Dentsply Sirona has expanded its partnership with Nashville Dental, Inc (NDI) to distribute its full range of connected technology solutions in the Southeast and Mid-Atlantic regions.
Effective August 1, 2026, NDI will offer the CEREC system, Primescan intraoral scanners, and digital imaging solutions across a nine-state territory.
The move strengthens Dentsply Sirona’s indirect channel strategy, aiming to improve customer accessibility and drive adoption of digital dentistry workflows through trusted local distributors.
• 5mo ago AI analysis › Press Release
Dentsply Sirona to Participate in the 2026 Stifel Jaws & Paws Conference
Dentsply Sirona will participate in the 2026 Stifel Jaws & Paws Conference.
Management is scheduled to present on Wednesday, May 27, 2026, at 3:35 p.m. ET.
A live audio webcast and replay will be available on the company's investor relations website.
• 5mo ago AI analysis › Press Release ⚠ 2
Dentsply Sirona Reports First Quarter 2026 Results
Dentsply Sirona reported Q1 net sales of $880 million, roughly flat year-over-year, but swung to a GAAP net loss of $0.05 per share.
Adjusted EPS fell 39% to $0.27 amid $68 million in restructuring and other costs, though operating cash flow improved to $40 million.
The company launched its AI-enabled Smart View-Detect diagnostic aid and reiterated its full-year outlook for sales and adjusted EPS.
• 6mo ago AI analysis › Press Release
Dentsply Sirona Expands U.S. Distribution Footprint Through Enhanced Agreement with Atlanta Dental Supply
Dentsply Sirona entered an enhanced distribution agreement with Atlanta Dental Supply to offer its connected technology solutions in the U.S. starting August 1.
The partnership leverages Atlanta Dental's established regional presence in the Southeast to expand the reach of digital dentistry offerings like the CEREC system.
Executives highlighted the deal as a core element of the company's commercial strategy to deepen market penetration through trusted partners.
• 6mo ago AI analysis › Press Release
Dentsply Sirona Launches Smart View - Detect, World’s First FDA-Cleared AI-enabled diagnostic aid for detecting teeth with Periapical Radiolucencies in CBCTs
Dentsply Sirona announced the launch of Smart View - Detect, the world's first FDA-cleared AI-enabled diagnostic aid for detecting periapical radiolucencies in CBCT scans.
An internal clinical study demonstrated that the feature increases tooth-level detection sensitivity by approximately 46% relative to unaided review, without increasing false positives.
Available starting May 12, 2026, via the DS Core platform, the software integrates with existing CBCT systems to streamline workflows and enhance patient communication.
• 6mo ago AI analysis › Press Release
Wellspect HealthCare Expands Surity™ Portfolio in the U.S. with Surity™ Male External Catheter for Urinary Incontinence Care
Wellspect HealthCare, a subsidiary of Dentsply Sirona, launched the Surity Male External Catheter in the U.S. to address urinary incontinence in men.
The non-invasive device is designed for up to 24 hours of wear and complements the previously released female version, with a full urinary management system anticipated soon.
Severe urinary incontinence affects more than 13 million Americans, and this launch aims to fill a gap in comfortable, user-friendly care solutions.
• 6mo ago AI analysis › Press Release
Dentsply Sirona to Host First Quarter 2026 Conference Call on May 5
Dentsply Sirona announced it will host an investor conference call on May 5, 2026, at 4:30 p.m. ET to review its first quarter 2026 financial results.
Financial earnings materials will be made available on the Investors section of the company’s website prior to the start of the call.
Investors can access the live webcast and replay via the company's website, with registration required for phone participation.
• 6mo ago AI analysis › 
